Genetic Prostate Cancer Test

The Genetic Prostate Cancer Panel provides a comprehensive genetic screening that assesses your inherited risk of prostate cancer, one of the most common cancers affecting men worldwide. This simple, non-invasive saliva test offers essential insights that can help you make proactive health decisions. Suitable for anyone aged 18 and over, this test is particularly valuable for those with a family history of prostate cancer or related genetic mutations.

Prostate cancer is the most commonly diagnosed cancer among men in the UK, with around 52,000 new cases and over 12,000 deaths annually. Globally, prostate cancer affects nearly 1.3 million men each year. Prostate cancer occurs when cells in the prostate gland grow uncontrollably, often forming a tumour. While early stages of prostate cancer may not show symptoms, understanding your genetic risk can support early detection and intervention, leading to better outcomes.

This test screens for specific genetic mutations linked to an increased risk of prostate cancer. Mutations in certain genes can elevate your risk, making this test an essential tool for understanding hereditary prostate cancer risks.

BRCA2: While commonly associated with breast cancer, BRCA2 mutations are also linked to prostate cancer and significantly increase risk.

HOXB13: Mutations in this gene are known to increase the risk of early-onset prostate cancer.

ATM: This gene plays a role in DNA repair, and mutations in ATM are associated with an increased prostate cancer risk.

CHEK2 and NBN: Mutations in these genes are associated with a moderate increase in prostate cancer risk, particularly in those with a family history.

Our Prostate Cancer Panel provides a personalised approach to understanding prostate cancer risk through Genome Nanopore Sequencing (GNS) technology, which enables accurate identification of specific genetic mutations. By detecting these mutations, our £449 test offers valuable insights, allowing you to discuss preventive options or enhanced screenings with your healthcare provider.

Convenient at-home saliva test: Conduct the test in the privacy and comfort of your own home without clinic visits.

Quick, accurate results: Access a detailed report via secure email within 15 days.

Comprehensive insights into prostate cancer risk: This panel is specifically designed to evaluate genetic risks for prostate cancer.

Non-invasive: A simple saliva swab provides essential genetic data to inform your health journey.

Order Online: Place your secure order through our website.

Collect Your Saliva Sample: Use the kit’s step-by-step instructions for sample collection.

Return Your Sample: Return your saliva swab using a temperature-controlled courier for secure, accurate analysis.

Receive Your Results: Your personalised report will be securely emailed within 15 days, detailing any genetic mutations and associated risks.

The Genetic Prostate Cancer Panel is suitable for anyone over 18 who wants to understand their genetic risk for prostate cancer. Men with a family history of prostate cancer or with Ashkenazi Jewish heritage, which is linked to higher incidences of BRCA mutations, may find this test particularly beneficial. Early awareness of genetic risks allows for proactive steps toward prevention, including more frequent screenings and potential lifestyle modifications.

Genetic testing provides invaluable insights, particularly for individuals with a genetic predisposition to prostate cancer. With the Genetic Prostate Cancer Panel, you gain knowledge that supports early detection, preventive care, and proactive health decisions. If you receive a positive result, discussing it with your healthcare provider can help guide the next steps.

Order Your Genetic Prostate Cancer Panel for £499.00 and take a proactive step toward understanding your health today.